And what does it mean for me? After President Obama announced the Administration’s Precision Medicine Initiative in his January, 2015 State of the Union Address, internet searches for “precision medicine”…
Read More
Recent data suggests that most of us are not normal when it comes to drug metabolism because of our genetics. In a recent retrospective analysis published in the American Journal…
Read More
Designation recognizes the development of new solutions that benefit the health care industry Seattle, WA; January 27, 2015 – Genelex announced its YouScript® Precision Prescribing analytics software has received Innovative…
Read More
“As both a Mental Health Therapist and a patient, I really believe drug sensitivity testing should be done for everyone. “ My name is Patricia. In 2005 I was diagnosed…
Read More
Have you ever taken a vitamin, herbal product or supplement? You’re not alone. In fact, an estimated one-quarter, up to one-half, of adults taking prescription medications also take dietary supplements…
Read More
“…the possibility he could have suffered a horrible consequence is very real.” –Sarah Zeller Full disclosure: I am currently employed by Genelex Corporation and have been since 2011. However, I…
Read More
CYP2D6 gene testing for personalizing tamoxifen therapy has been a source of confusion and debate for over a decade. In addition to conflicting outcomes data on breast cancer recurrence rates…
Read More
As a provider of drug interaction clinical decision support and predictive analytics, we recognize that our efforts would not be possible without the scientists and clinicians who’ve spent thousands of hours…
Read More
Is it time to reconsider long-term use of four large classes of cardiovascular drugs? In a review article recently published in the Journal of the American College of Cardiology, the…
Read More
Naloxone, a medication used to pull individuals from the brink of an opioid overdose, can save lives. That’s the message government agencies and medical societies are broadcasting as they strengthen…
Read More
